• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服结肠给药系统的设计与应用。

Design and application of oral colon administration system.

机构信息

Chongqing Key Laboratory of Green Synthesis and Application, Active Carbohydrate Research Institute, Chongqing Normal University , Chongqing , China.

出版信息

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1590-1596. doi: 10.1080/14756366.2019.1655406.

DOI:10.1080/14756366.2019.1655406
PMID:31581863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6781185/
Abstract

Oral colon administration system has become a new method to treat intestinal diseases. The implementation of colon drug delivery system is restricted by many aspects, including physical and chemical properties, drug delivery mode, gastrointestinal physiological factors, and so on. Delivery methods to overcome these challenges revolve around the mechanisms of drug delivery, including the use of rational dosage forms to avoid the complex pH environment, and the prevention of drug release and absorption in the upper digestive tract.

摘要

口服结肠给药系统已成为治疗肠道疾病的一种新方法。结肠药物传递系统的实施受到许多因素的限制,包括物理化学性质、药物传递方式、胃肠道生理因素等。克服这些挑战的传递方法围绕着药物传递机制展开,包括使用合理的剂型来避免复杂的 pH 环境,以及防止药物在上消化道中的释放和吸收。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cea/6781185/335907234b4c/IENZ_A_1655406_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cea/6781185/335907234b4c/IENZ_A_1655406_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cea/6781185/335907234b4c/IENZ_A_1655406_F0001_B.jpg

相似文献

1
Design and application of oral colon administration system.口服结肠给药系统的设计与应用。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1590-1596. doi: 10.1080/14756366.2019.1655406.
2
Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review.纳米技术在解决口服药物传递挑战中的相关性:观点综述。
Crit Rev Ther Drug Carrier Syst. 2020;37(5):407-434. doi: 10.1615/CritRevTherDrugCarrierSyst.2020032583.
3
Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.基于回生淀粉/果胶的结肠定位型微粒在壳聚糖纳米粒沿胃肠道传递中的作用研究。
Eur J Pharm Biopharm. 2021 Jan;158:371-378. doi: 10.1016/j.ejpb.2020.12.004. Epub 2020 Dec 10.
4
Design of nanoparticles composed of graft copolymers for oral peptide delivery.用于口服肽递送的接枝共聚物组成的纳米颗粒设计
Adv Drug Deliv Rev. 2001 Mar 23;47(1):21-37. doi: 10.1016/s0169-409x(00)00119-8.
5
HEMA based pH-sensitive semi IPN microgels for oral delivery; a rationale approach for ketoprofen.基于 HEMA 的 pH 敏感半互穿网络微凝胶用于口服递药;酮洛芬的合理方法。
Drug Dev Ind Pharm. 2020 Feb;46(2):272-282. doi: 10.1080/03639045.2020.1716378. Epub 2020 Jan 22.
6
A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.一种新型双层包衣方法,可改善对胃肠道回肠结肠区域的 pH 触发递药。
Eur J Pharm Biopharm. 2010 Feb;74(2):311-5. doi: 10.1016/j.ejpb.2009.11.008. Epub 2009 Nov 20.
7
Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery.打印填充:结合熔融沉积建模和注射体积填充的 3D 打印系统。在结肠定位药物释放中的应用。
Eur J Pharm Biopharm. 2019 Jan;134:138-143. doi: 10.1016/j.ejpb.2018.11.021. Epub 2018 Nov 24.
8
Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.通过机械化学法制备无交联剂的 5-ASA 结肠特异性水凝胶递药系统的研究。
Pharm Res. 2021 Apr;38(4):693-706. doi: 10.1007/s11095-021-02993-2. Epub 2021 Mar 22.
9
Extrudable core system: development of a single-layer osmotic controlled-release tablet.可挤出核心系统:单层渗透控释片的研发
J Control Release. 2009 Mar 19;134(3):201-6. doi: 10.1016/j.jconrel.2008.11.017. Epub 2008 Dec 3.
10
Oral Nano-Delivery Systems for Colon Targeting Therapy.用于结肠靶向治疗的口服纳米给药系统。
Pharm Nanotechnol. 2017;5(2):83-94. doi: 10.2174/2211738505666170424122722.

引用本文的文献

1
Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives.结直肠癌:疾病进程、当前治疗选择及未来展望
Pharmaceutics. 2023 Nov 12;15(11):2620. doi: 10.3390/pharmaceutics15112620.
2
Microfluidic-Assisted Production of Gastro-Resistant Active-Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells.微流控辅助生产抗胃活性靶向硅藻土纳米颗粒用于转移性结直肠癌细胞中海仑胶的局部释放
Adv Healthc Mater. 2023 Jan;12(6):e2202672. doi: 10.1002/adhm.202202672. Epub 2022 Dec 11.
3
Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases.

本文引用的文献

1
Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis.用于治疗溃疡性结肠炎的5-氨基水杨酸和丁酸的结肠靶向互变异构前药。
RSC Adv. 2018 Jan 11;8(5):2561-2574. doi: 10.1039/c7ra13011b. eCollection 2018 Jan 9.
2
Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.具有 pH 敏感性壳聚糖/海藻酸钠/ Eudragit S 多层结构的结肠靶向型地塞米松微晶体,用于治疗炎症性肠病。
Carbohydr Polym. 2018 Oct 15;198:434-442. doi: 10.1016/j.carbpol.2018.06.107. Epub 2018 Jun 26.
3
Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats.
用于癌症或自身免疫性疾病结肠给药的美洛昔康多微粒系统。
Pharmaceutics. 2022 Jul 20;14(7):1504. doi: 10.3390/pharmaceutics14071504.
4
Pathways for Oral and Rectal Delivery of Gold Nanoparticles (1.7 nm) and Gold Nanoclusters into the Colon: Enteric-Coated Capsules and Suppositories.口服和直肠递送入结肠的 1.7nm 金纳米粒子和金纳米团簇的途径:肠溶胶囊和栓剂。
Molecules. 2021 Aug 21;26(16):5069. doi: 10.3390/molecules26165069.
5
Safety of oral administration of high doses of ivermectin by means of biocompatible polyelectrolytes formulation.通过生物相容性聚电解质制剂口服高剂量伊维菌素的安全性。
Heliyon. 2021 Jan;7(1):e05820. doi: 10.1016/j.heliyon.2020.e05820. Epub 2020 Dec 31.
6
Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery.基于壳聚糖及其衍生物的纳米颗粒的最新进展:口服胰岛素递送的药学视角
Pharmaceuticals (Basel). 2020 Oct 14;13(10):307. doi: 10.3390/ph13100307.
测定在 Wistar 大鼠实验性结肠炎模型中麦考酚酸和氨基糖的结肠特异性生物可逆偶联物的缓解作用。
World J Gastroenterol. 2018 Mar 14;24(10):1093-1106. doi: 10.3748/wjg.v24.i10.1093.
4
Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.载姜黄素壳聚糖基 pH 敏感聚合物胶束的制备及其结肠靶向给药研究。
AAPS PharmSciTech. 2018 Apr;19(3):991-1000. doi: 10.1208/s12249-017-0906-y. Epub 2017 Nov 6.
5
A novel controlled drug delivery system based on alginate hydrogel/chitosan micelle composites.基于海藻酸钠水凝胶/壳聚糖胶束复合材料的新型控释给药系统。
Int J Biol Macromol. 2018 Feb;107(Pt A):855-864. doi: 10.1016/j.ijbiomac.2017.09.065. Epub 2017 Sep 19.
6
Electrospun core-shell structured nanofilm as a novel colon-specific delivery system for protein.静电纺丝核壳结构纳米纤维作为一种新型的蛋白质结肠定位给药系统。
Carbohydr Polym. 2017 Aug 1;169:157-166. doi: 10.1016/j.carbpol.2017.03.082. Epub 2017 Mar 29.
7
Superabsorbent hydrogel made of NaAlg-g-poly(AA-co-AAm) and rice husk ash: Synthesis, characterization, and swelling kinetic studies.由 NaAlg-g-poly(AA-co-AAm) 和稻壳灰制成的高吸水性水凝胶:合成、表征和溶胀动力学研究。
Carbohydr Polym. 2017 Jul 15;168:1-13. doi: 10.1016/j.carbpol.2017.03.047. Epub 2017 Mar 16.
8
pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.pH响应性聚(丙烯酸)门控介孔二氧化硅及其在阿霉素口服结肠靶向给药中的应用。
Colloids Surf B Biointerfaces. 2017 Jun 1;154:287-296. doi: 10.1016/j.colsurfb.2017.03.024. Epub 2017 Mar 14.
9
Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.通过双层肠溶包衣多单元片剂实现可溶性比沙可啶的结肠靶向递送。
Eur J Pharm Sci. 2017 May 1;102:172-179. doi: 10.1016/j.ejps.2017.03.006. Epub 2017 Mar 6.
10
Electrospun polyurethane nanofiber scaffolds with ciprofloxacin oligomer versus free ciprofloxacin: Effect on drug release and cell attachment.载有环丙沙星低聚物的静电纺丝聚氨酯纳米纤维支架与游离环丙沙星的比较:对药物释放和细胞黏附的影响。
J Control Release. 2017 Mar 28;250:107-115. doi: 10.1016/j.jconrel.2017.02.008. Epub 2017 Feb 10.